H.pylori gastric lymphoma pathophysiology: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{{Helicobacter pylori infection}} {{CMG}}; {{AE}}{{YK}} ==Overview== ==References== {{Reflist|2}}") |
No edit summary |
||
| (4 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Helicobacter pylori infection}} | {{Helicobacter pylori infection}} | ||
{{CMG}}; {{AE}}{{YK}} | {{CMG}}; {{AE}}{{YK}} | ||
| Line 5: | Line 6: | ||
==Pathophysiology== | |||
For further information on MALT lymphoma please click [[MALT lymphoma|here]] | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Latest revision as of 18:17, 13 January 2017
|
Helicobacter pylori infection Microchapters |
|
Differentiating Helicobacter pylori infection from other Diseases |
|---|
|
Diagnosis |
|
Guideline Recommendation |
|
Treatment |
|
Case Studies |
|
H.pylori gastric lymphoma pathophysiology On the Web |
|
American Roentgen Ray Society Images of H.pylori gastric lymphoma pathophysiology |
|
Directions to Hospitals Treating Helicobacter pylori infection |
|
Risk calculators and risk factors for H.pylori gastric lymphoma pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[2]
Overview
Pathophysiology
For further information on MALT lymphoma please click here